Publications by authors named "Larissa A Derzko-Dzulynsky"
Article Synopsis
- - The study examines the long-term outcomes of patients with noninfectious uveitis (NIU) who received systemic immunomodulatory therapy (IMT) at five specialized clinics between 2010 and 2021.
- - A total of 418 adult patients had varying responses to treatments, with infliximab, cyclosporine, and adalimumab showing the highest effectiveness.
- - Key findings indicate that younger patients, those with more severe conditions, and chronic cases often need multiple treatments, while initial vision quality is crucial in predicting final visual acuity.
Objective: Ocular hypertension and uveitic glaucoma are important downstream sequela of noninfectious uveitis (NIU). Herein, we describe the clinical outcomes of NIU cases with ocular hypertension and uveitic glaucoma.
Design: Retrospective cohort study.
Objective: To compare the patient characteristics and long-term outcomes for those treated with and without systemic immunomodulatory therapy (IMT) for non-infectious uveitis (NIU).
Design: Retrospective cohort study.
Participants: All consecutive adults with NIU receiving care at 5 uveitis subspecialty tertiary care clinics between 2010 and 2021.
Purpose: To characterize optical coherence tomography features in patients with idiopathic intermediate, posterior, or panuveitis.
Methods: This is a retrospective case series of all consecutive cases of idiopathic intermediate, posterior, or panuveitis at four tertiary care centres between 2010 and 2021.
Results: A total of 94 eyes (55 patients) were followed for an average duration of 29.
Objective: To assess the characteristics of referrals to academic uveitis tertiary care centres in Toronto and identify determinants of wait time for consultation.
Design: Retrospective case series.
Methods: Consecutive new uveitis referrals received at 5 University of Toronto-affiliated uveitis tertiary care centres, between February 2016 and November 2016, were included.